Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Data Sharing to Support the Cancer Journey in the Digital Era.
Krauss JC, Warner JL, Maddux SE, Brown JR, Moldwin R, Schorer AE, Hughes KS, Ambinder EP. Krauss JC, et al. J Oncol Pract. 2016 Mar;12(3):201-7. doi: 10.1200/JOP.2015.007740. Epub 2016 Jan 12. J Oncol Pract. 2016. PMID: 26759494 No abstract available.
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Klute KA, Rothe M, Garrett-Mayer E, Mangat PK, Nazemzadeh R, Yost KJ, Duvivier HL, Ahn ER, Cannon TL, Alese OB, Krauss JC, Thota R, Calfa CJ, Denlinger CS, O'Lone R, Halabi S, Grantham GN, Schilsky RL. Klute KA, et al. Among authors: krauss jc. JCO Precis Oncol. 2022 Nov;6:e2200191. doi: 10.1200/PO.22.00191. JCO Precis Oncol. 2022. PMID: 36409971
Efficacy of the Motivational Interviewing-Walk Intervention for Chemotherapy-Induced Peripheral Neuropathy and Quality of Life During Oxaliplatin Treatment: A Pilot Randomized Controlled Trial.
Kanzawa-Lee GA, Ploutz-Snyder RJ, Larson JL, Krauss JC, Resnicow K, Lavoie Smith EM. Kanzawa-Lee GA, et al. Among authors: krauss jc. Cancer Nurs. 2022 Mar-Apr 01;45(2):E531-E544. doi: 10.1097/NCC.0000000000001003. Cancer Nurs. 2022. PMID: 34483279 Clinical Trial.
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Meric-Bernstam F, Rothe M, Mangat PK, Garrett-Mayer E, Gutierrez R, Ahn ER, Cannon TL, Powell S, Krauss JC, Reynolds CM, von Mehren M, Behl D, Calfa CJ, Duvivier HL, Kaplan HG, Livingston MB, Sharma MR, Urba WJ, Grantham GN, Hinshaw DC, Gregory A, Halabi S, Schilsky RL. Meric-Bernstam F, et al. Among authors: krauss jc. JCO Precis Oncol. 2023 Sep;7:e2300385. doi: 10.1200/PO.23.00385. JCO Precis Oncol. 2023. PMID: 38096472
79 results